Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO).

Volgger BM, Windbichler GH, Zeimet AG, Graf AH, Bogner G, Angleitner-Boubenizek L, Rohde M, Denison U, Sliutz G, Fuith LC, Fuchs D, Marth C.

Ann Oncol. 2016 Sep;27(9):1740-6. doi: 10.1093/annonc/mdw248. Epub 2016 Jun 29.

2.

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.

du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO, Merger M, Harter P; AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium.

Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16.

PMID:
26590673
3.

Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2008 Apr 1;14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.

4.

Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer.

Peters-Engl C, Cassik P, Schmidt I, Denison U, Medl M, Pokieser W, Sevelda P.

Acta Oncol. 2005;44(2):129-33.

PMID:
15788291
5.

Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.

Denison U, Baumann J, Peters-Engl C, Samonigg H, Krippl P, Lang A, Obermair A, Wagner H, Sevelda P.

Breast Cancer Res Treat. 2003 Jun;79(3):347-53.

PMID:
12846419
6.

Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? A clinical study.

Peters-Engl C, Medl M, Denison U, Sevelda P, Leodolter S, Petru E.

Anticancer Res. 2001 Sep-Oct;21(5):3701-6.

PMID:
11848547
7.

Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases.

Peters-Engl C, Frank W, Kerschbaum F, Denison U, Medl M, Sevelda P.

Breast Cancer Res Treat. 2001 Nov;70(2):131-5.

PMID:
11768603
8.

Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.

Obermair A, Geramou M, Gücer F, Denison U, Graf AH, Kapshammer E, Medl M, Rosen A, Wierrani F, Neunteufel W, Frech I, Speiser P, Kainz C, Breitenecker G.

Int J Gynecol Cancer. 1999 Sep;9(5):383-386.

PMID:
11240798
9.

Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients.

Obermair A, Geramou M, Gücer F, Denison U, Graf AH, Kapshammer E, Medl M, Rosen A, Wierrani F, Neunteufel W, Frech I, Preyer O, Speiser P, Kainz C.

Int J Gynecol Cancer. 2000 Jul;10(4):275-279.

PMID:
11240686
10.

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial.

Windbichler GH, Hausmaninger H, Stummvoll W, Graf AH, Kainz C, Lahodny J, Denison U, Müller-Holzner E, Marth C.

Br J Cancer. 2000 Mar;82(6):1138-44.

11.

Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C.

Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, Neunteufel W, Frech I, Kaider A, Kainz C.

Cancer. 2000 Jan 1;88(1):139-43.

PMID:
10618616
12.

[Influence of adjuvant hormonal therapy on the whole female organism: benefit versus potential injury].

Denison U, Riegler-Keil M, Salzer H.

Gynakol Geburtshilfliche Rundsch. 1998;38(2):96-100. Review. German.

PMID:
9815526
13.

Prognostic factors related to recurrent endometrial carcinoma following initial surgery.

Vavra N, Denison U, Kucera H, Barrada M, Kurz C, Salzer H, Sevelda P.

Acta Obstet Gynecol Scand. 1993 Apr;72(3):205-9.

PMID:
8385857
14.

[Homeopathic management of labor].

Matal W, Denison U, Fidi C, Wisleitner R.

Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:339. German. No abstract available.

15.

[Is internal peritonealization after cesarean section necessary? Results of a randomized study].

Lange M, Schmidt J, Tatschl S, Denison U, Salzer H.

Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:264. German. No abstract available.

16.

[Value of intrapartum micro-blood gas analysis in obstetric decision making].

Salzer H, Denison U, Wisleitner R, Neumann M.

Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:147-8. German. No abstract available.

17.

Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?

Sevelda P, Rosen A, Denison U, Barrada M, Spona J, Salzer H.

Gynecol Oncol. 1991 Nov;43(2):154-8.

PMID:
1743558
18.

[The value of adjuvant irradiation in patients with cervical carcinoma in histopathological stage Ib and negative lymph nodes].

Vavra N, Kucera H, Denison U, Salzer H, Schemper M, Sevelda P.

Strahlenther Onkol. 1991 Sep;167(9):509-13. German.

PMID:
1925933
19.

[Possibilities and goals in after care of breast cancer].

Seifert M, Adler A, Obermair A, Hartmann B, Denison U, Kubista E, Sevelda P.

Gynakol Rundsch. 1991;31 Suppl 2:309-11. German. No abstract available.

PMID:
1665141
20.

[The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].

Sevelda P, Barrada M, Vavra N, Denison U, Schmidl S, Genger H, Salzer H.

Wien Klin Wochenschr. 1990 Aug 3;102(15):441-3. German.

PMID:
2402929
21.

[The value of surgical staging in the early stages of ovarian carcinoma].

Salzer H, Sevelda P, Genger H, Schmidl S, Denison U, Barrada M, Vavra N, Kucera H.

Wien Klin Wochenschr. 1990 Aug 3;102(15):437-40. German.

PMID:
2402928
22.

Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.

Sevelda P, Denison U, Schemper M, Spona J, Vavra N, Salzer H.

Br J Obstet Gynaecol. 1990 Aug;97(8):706-12.

PMID:
2400748
23.

[Detection of asymptomatic bacteriuria in the puerperium using a test strip].

Denison U, Wenzl R, Reichel R, Philipp K.

Gynakol Rundsch. 1989;29 Suppl 2:331-2. German. No abstract available.

PMID:
2693253
24.

[The treatment of virus-associated cervix dysplasia with recombinant interferon alpha-2c or gamma].

Reichel R, Fitz R, Budiman R, Czerwenka K, Breitenecker G, Denison U.

Gynakol Rundsch. 1989;29 Suppl 2:94-6. German. No abstract available.

PMID:
2559003
25.

[Recombinant alpha and/or gamma interferon in the treatment of 45 patients with condylomata acuminata].

Reichel R, Fitz R, Denison U, Genger H, Vavra N.

Gynakol Rundsch. 1989;29 Suppl 2:350-1. German. No abstract available.

PMID:
2515124

Supplemental Content

Loading ...
Support Center